Improved health outcomes with donepezil in moderate to severe Alzheimer's disease are associated with economic benefits

被引：0
|
作者：
Feldman, H
Gauthier, S
Hecker, J
Vellas, B
Hux, M
Emir, B
Subbiah, P
Mastey, V
机构：
[1] Pfizer Inc, New York, NY USA
[2] Innovus Res Inc, Burlington, ON, Canada
[3] Toulouse Univ, Alzheimers Ctr, Toulouse, France
[4] Repatriat Gen Hosp, Daw Pk, Australia
[5] McGill Ctr Studies Aging, Verdun, PQ, Canada
[6] UBC Hosp, Div Neurol, Vancouver, BC, Canada
来源：
NEUROBIOLOGY OF AGING | 2002年 / 23卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
285
引用
收藏
页码：S74 / S75
页数：2
相关论文
共 50 条
  • [41] Functional benefits of memantine treatment for patients with moderate to severe Alzheimer's disease
    Wirth, Y
    Doody, RS
    Schmitt, FA
    Möbius, HJ
    [J]. NEUROBIOLOGY OF AGING, 2004, 25 : S205 - S205
  • [42] Effect of memantine on behavioral outcomes in moderate to severe Alzheimer's disease
    Cummings, JL
    Schneider, E
    Tariot, PN
    Graham, SM
    [J]. NEUROPSYCHOPHARMACOLOGY, 2004, 29 : S127 - S127
  • [43] An economic evaluation of donepezil in the treatment of Alzheimer's disease
    Small, GW
    Donohue, JA
    Brooks, RL
    [J]. CLINICAL THERAPEUTICS, 1998, 20 (04) : 838 - 850
  • [44] Memantine/donepezil dual-therapy is superior to placebo/donepezil therapy for treatment of moderate to severe Alzheimer's disease.
    Tariot, R
    Farlow, M
    Grossberg, G
    Gergel, I
    Graham, S
    Jin, J
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2003, 51 (04) : S225 - S226
  • [45] Analyzing the impact of 23 mg/day donepezil on language dysfunction in moderate to severe Alzheimer's disease
    Steven H Ferris
    Frederick A Schmitt
    Judith Saxton
    Sharon Richardson
    Joan Mackell
    Yijun Sun
    Yikang Xu
    [J]. Alzheimer's Research & Therapy, 3
  • [46] Efficacy of Memantine, Donepezil, or Their Association in Moderate-Severe Alzheimer's Disease: A Review of Clinical Trials
    Molino, Ivana
    Colucci, Luisa
    Fasanaro, Angiola M.
    Traini, Enea
    Amenta, Francesco
    [J]. SCIENTIFIC WORLD JOURNAL, 2013,
  • [47] The donepezil transdermal system for the treatment of patients with mild, moderate, or severe Alzheimer's disease: a critical review
    Buck, Austin
    Rezaei, Kayvon
    Quazi, Aman
    Goldmeier, Gary
    Silverglate, Bret
    Grossberg, George T.
    [J]. EXPERT REVIEW OF NEUROTHERAPEUTICS, 2024, 24 (06) : 607 - 614
  • [48] DOMINO-AD protocol: donepezil and memantine in moderate to severe Alzheimer's disease - a multicentre RCT
    Jones, Rob
    Sheehan, Bart
    Phillips, Patrick
    Juszczak, Ed
    Adams, Jessica
    Baldwin, Ashley
    Ballard, Clive
    Banerjee, Sube
    Barber, Bob
    Bentham, Peter
    Brown, Richard
    Burns, Alistair
    Dening, Tom
    Findlay, David
    Gray, Richard
    Griffin, Mary
    Holmes, Clive
    Hughes, Alan
    Jacoby, Robin
    Johnson, Tony
    Jones, Roy
    Knapp, Martin
    Lindesay, James
    McKeith, Ian
    McShane, Rupert
    Macharouthu, Ajay
    O'Brien, John
    Onions, Caroline
    Passmore, Peter
    Raftery, James
    Ritchie, Craig
    Howard, Rob
    [J]. TRIALS, 2009, 10
  • [49] DOMINO-AD protocol: donepezil and memantine in moderate to severe Alzheimer's disease – a multicentre RCT
    Rob Jones
    Bart Sheehan
    Patrick Phillips
    Ed Juszczak
    Jessica Adams
    Ashley Baldwin
    Clive Ballard
    Sube Banerjee
    Bob Barber
    Peter Bentham
    Richard Brown
    Alistair Burns
    Tom Dening
    David Findlay
    Richard Gray
    Mary Griffin
    Clive Holmes
    Alan Hughes
    Robin Jacoby
    Tony Johnson
    Roy Jones
    Martin Knapp
    James Lindesay
    Ian McKeith
    Rupert McShane
    Ajay Macharouthu
    John O'Brien
    Caroline Onions
    Peter Passmore
    James Raftery
    Craig Ritchie
    Rob Howard
    [J]. Trials, 10
  • [50] Analyzing the impact of 23 mg/day donepezil on language dysfunction in moderate to severe Alzheimer's disease
    Ferris, Steven H.
    Schmitt, Frederick A.
    Saxton, Judith
    Richardson, Sharon
    Mackell, Joan
    Sun, Yijun
    Xu, Yikang
    [J]. ALZHEIMERS RESEARCH & THERAPY, 2011, 3 (03):
12345